Retrospective cohort study 132 immune checkpoint inhibitor arthritis pts Rx with either TNFi ± MTX or IL6Ri ± MTX have a shorter time to cancer progression but faster arthritis control than patients Rx with MTX alone. Bass A Abs#1669 https://t.co/h0Nq6yd2wf #ACR22 @RheumNow https://t.co/XfXMtdbCPB
Links:
Comparing the Safety and Effectiveness of Methotrexate, TNF and IL6 Inhibitors …
http://bit.ly/3UYF4ZY
14-11-2022